No Data
No Data
No Data
No Data
No Data
Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug
Seeking AlphaApr 23 10:29 ET
Avidity Biosciences(RNA.US) Director Sells US$114.12K in Common Stock
$Avidity Biosciences(RNA.US)$ Director LEVIN ARTHUR A sold 5,000 shares of common stock on Apr 19, 2024 at an average price of $22.8246 for a total value of $114.12K.Source: Announcement What is state
moomoo NewsApr 22 18:10 ET
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Moomoo 24/7Apr 22 16:05 ET
FYBR, BCRX and SABR Are Among After Hour Movers
Seeking AlphaApr 18 16:56 ET
Express News | Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target
Moomoo 24/7Apr 11 07:23 ET
Analysts Offer Insights on Healthcare Companies: Carisma Therapeutics (CARM), Avidity Biosciences (RNA) and Vera Therapeutics (VERA)
TipRanksApr 11 06:40 ET
No Data
No Data